Bridging the gap between innovation and capital
Civilization Ventures
Focus on Biotech Therapeutic Companies
Program
Civilization Ventures is a California-based early-stage investment firm focused on fueling the next generation of breakthroughs in health and biology.
Event
LaunchBio, Browne Consulting, and Silicon Valley Bank, a division of First Citizens Bank, with support by Fondation Ipsen, are pleased to announce their next Investor Connect virtual event with Civilization Ventures.
They partner with scientific founders building diagnostic platforms, frontier therapeutics, precision medicine pipelines, digital health ecosystems, enabling tools and instrumentation, and AI-driven approaches that transform how care is delivered and diseases are understood. With a founder-centric mindset, Civilization Ventures catalyzes innovations that push the frontier of medicine.
Applications will be selected based on meeting the following criteria:
Geography
Open to investments in North America, UK and Europe
Company type
Early-stage biotech companies.
Modalities of Interest
- Biologics
- Cell therapies
- CRISPR-based therapies
- Gene therapies
- Microbiome-based therapies
- Protein-based therapies
- Regenerative Medicine
- RNA-based therapeutics
- Small molecule
- Vaccines
Stage
Companies seeking funding for Pre-Seed, Seed and Series A.
Qualifying start-ups can apply here today.
Applications are accepted on a rolling basis. Learn more about LaunchBio’s Investor Connect series, in partnership with Browne Consulting and Silicon Valley Bank, a division of First Citizens Bank.